347 related articles for article (PubMed ID: 31827763)
1. Signaling pathways involved in colorectal cancer progression.
Koveitypour Z; Panahi F; Vakilian M; Peymani M; Seyed Forootan F; Nasr Esfahani MH; Ghaedi K
Cell Biosci; 2019; 9():97. PubMed ID: 31827763
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
3. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.
Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Zhang J; Manna PP; Daglia M; Atanasov AG; Battino M
Biotechnol Adv; 2020; 38():107322. PubMed ID: 30476540
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy.
Kasper S; Reis H; Ziegler S; Nothdurft S; Mueller A; Goetz M; Wiesweg M; Phasue J; Ting S; Wieczorek S; Even A; Worm K; Pogorzelski M; Breitenbuecher S; Meiler J; Paul A; Trarbach T; Schmid KW; Breitenbuecher F; Schuler M
Oncotarget; 2017 Jul; 8(28):45898-45917. PubMed ID: 28507280
[TBL] [Abstract][Full Text] [Related]
5. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment.
Maurya NS; Mani A
Curr Top Med Chem; 2023; 23(30):2821-2843. PubMed ID: 37317918
[TBL] [Abstract][Full Text] [Related]
6. Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review.
Najafi M; Ahmadi A; Mortezaee K
Cell Biol Int; 2019 Nov; 43(11):1206-1222. PubMed ID: 31136035
[TBL] [Abstract][Full Text] [Related]
7. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
Liu X; Ji Q; Fan Z; Li Q
Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of Targeting Transforming Growth Factor-beta in Colorectal Cancer: Rational and Progress.
Gachpazan M; Kashani H; Hassanian SM; Khazaei M; Khorrami S; Ferns GA; Avan A
Curr Pharm Des; 2019; 25(38):4085-4089. PubMed ID: 31692434
[TBL] [Abstract][Full Text] [Related]
9. Targeting the PI3K Signalling as a Therapeutic Strategy in Colorectal Cancer.
Fernandes MS; Sanches JM; Seruca R
Adv Exp Med Biol; 2018; 1110():35-53. PubMed ID: 30623365
[TBL] [Abstract][Full Text] [Related]
10. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
[TBL] [Abstract][Full Text] [Related]
11. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
14. Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer.
Nunez SK; Young CD; Griffen TL; Ohandjo AQ; McKinney LP; Kopetz S; Lillard JW
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830978
[TBL] [Abstract][Full Text] [Related]
15. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Ferns GA; Aghaee-Bakhtiari SH
Curr Pharm Des; 2018; 24(39):4611-4618. PubMed ID: 30636580
[TBL] [Abstract][Full Text] [Related]
16. The genetic factors associated with Wnt signaling pathway in colorectal cancer.
Aghabozorgi AS; Ebrahimi R; Bahiraee A; Tehrani SS; Nabizadeh F; Setayesh L; Jafarzadeh-Esfehani R; Ferns GA; Avan A; Rashidi Z
Life Sci; 2020 Sep; 256():118006. PubMed ID: 32593708
[TBL] [Abstract][Full Text] [Related]
17. Molecular therapy of colorectal cancer: progress and future directions.
Weng W; Feng J; Qin H; Ma Y
Int J Cancer; 2015 Feb; 136(3):493-502. PubMed ID: 24420815
[TBL] [Abstract][Full Text] [Related]
18. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
Itatani Y; Kawada K; Sakai Y
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
[TBL] [Abstract][Full Text] [Related]
20. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
